Image via WikipediaAccording to an FDA drug safety report, birth control drugs containing drospirenone, such as Yaz and Yasmin are 75% more likely to cause blood clots than older birth control pills. The findings are based on a study of 800,000 women between 2001 and 2007 by the FDA, Kaiser Permanente, Vanderbilt University and the University of Washington. According to the study there is a definite significant increased risk of blood clots associated with ingestion of birth control pills containing the progestin drospirenone.
The findings are timely and significant given the onslaught of litigation against Bayer, the makers of the popular birth control pills Yaz and Yasmin. Women have alleged that they have sustained significant injuries as a result of the pills, some of the plaintiffs even alleging that women ingesting the pills have died.
The study according to information from aboutlawsuits.com substantiated allegations that the newer birth control pills are responsible for increased blood clots and strokes. Researchers determined through the study that drospirenone birth control pills as a whole increased the risk of blood clots by 75%. It also increased by 50% the risk of heart attacks and strokes in new birth control patients. The study's findings supports allegations that the serious and sometimes fatal health problems associated with the pills occur quickly -- within three months or less after starting the regimen.
The findings of the study will be discussed at the December 8th meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee meeting. The Committees will then make a recommendation to the FDA on how it should proceed with regard to drospirenone based birth control pills.